Urology CME

Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
May 11, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
May 7, 2021
Credits: 1.00 CME / MOC
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
April 20, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
March 3, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
July 22, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape
July 8, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
June 22, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Innovative Treatments for Bladder Cancer: Thoughts From the Chair
June 22, 2020